Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET Notified -
Mùa bóng đá 2026 khởi tranh – LEPAS đồng hành cùng bạn theo đuổi đam mê với phong thái điềm tĩnh Notified -
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome Notified -
World Finance Awards 2026 Affirm Trusted, Reliable FX and CFD Trading for Clients Worldwide Notified -
General Fusion Achieves Compressional Plasma Heating with LM26 Magnetized Target Fusion Machine Notified -
Airia Named as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Governance Platforms Notified -
WeRide, Geely Farizon and Kwoon Chung Launch Right-Hand-Drive Robotaxis at the 2026 International Automotive & Supply Chain Expo (Hong Kong), Accelerating Global Expansion Notified -
Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers Notified -